Efficacy of Sacubitril-Valsartan on Survival and Cardiac Remodeling in Hypotensive Heart Failure With Reduced Ejection Fraction: A Multicenter Study-Reference-Cited by-同舟云学术

Efficacy of Sacubitril-Valsartan on Survival and Cardiac Remodeling in Hypotensive Heart Failure With Reduced Ejection Fraction: A Multicenter Study

Published:2024-06 Issue:6 Volume:99 Page:940-952
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Hsu Chien-Yi^ORCID,Chung Fa-Po,Chao Chieh-Ju,Chen Ying-Ju,Wu Cho-Kai^ORCID,Wu Yen-Wen^ORCID,Huang Jin-Long,Chu Pao-Hsien^ORCID,Jia-Yin Hou Charles^ORCID,Chang Hung-Yu^ORCID,Hung Chung-Lieh^ORCID

Publisher

Elsevier BV

Reference21 articles.

1. Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients;Cautela;Eur J Heart Fail,2020

2. Use of evidence-based therapy and survival in heart failure in Sweden 2003-2012;Thorvaldsen;Eur J Heart Fail,2016

3. Unraveling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use, and clinical outcomes: data from 9222 chronic heart failure patients from the ESC-HFA-EORP Heart Failure Long-Term Registry;Rossignol;Eur J Heart Fail,2020

4. Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey;Komajda;Eur J Heart Fail,2016

5. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Sacubitril/Valsartan on Survival in Patients with Heart Failure and Significant Valvular Heart Disease;Clinical Pharmacology & Therapeutics;2024-08-15